Summary of Significant Accounting Policies (Details) (USD $)
|
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2015
Segment
|
Mar. 31, 2014
|
Dec. 31, 2014
|
|
Summary of Significant Accounting Policies [Line Items] | |||
Net cash used in operating activities | $ 238,793,000us-gaap_NetCashProvidedByUsedInOperatingActivities | $ (22,611,000)us-gaap_NetCashProvidedByUsedInOperatingActivities | |
Net cash provided by financing activities | 13,812,000us-gaap_NetCashProvidedByUsedInFinancingActivities | (6,531,000)us-gaap_NetCashProvidedByUsedInFinancingActivities | |
Goodwill and intangible assets | 1,100,000,000opk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets | 1,100,000,000opk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets | |
Amortization of intangible assets | 2,665,000us-gaap_AmortizationOfIntangibleAssets | 2,744,000us-gaap_AmortizationOfIntangibleAssets | |
Revenue from services | 2,069,000us-gaap_SalesRevenueServicesNet | 1,970,000us-gaap_SalesRevenueServicesNet | |
Total deferred revenue related to other revenues | 288,800,000us-gaap_DeferredRevenue | 6,700,000us-gaap_DeferredRevenue | |
Allowance for doubtful accounts receivable | (1,691,000)us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent | (1,906,000)us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent | |
Equity-based compensation expense for continuing operations | 7,382,000us-gaap_ShareBasedCompensation | 3,579,000us-gaap_ShareBasedCompensation | |
Number of reportable segments | 2us-gaap_NumberOfReportableSegments | ||
Pharmaceutical | |||
Summary of Significant Accounting Policies [Line Items] | |||
Number of operating segments | 2us-gaap_NumberOfOperatingSegments / us-gaap_StatementBusinessSegmentsAxis = opk_PharmaceuticalMember |
||
Diagnostics | |||
Summary of Significant Accounting Policies [Line Items] | |||
Number of operating segments | 2us-gaap_NumberOfOperatingSegments / us-gaap_StatementBusinessSegmentsAxis = opk_DiagnosticsMember |
||
Neovasc | |||
Summary of Significant Accounting Policies [Line Items] | |||
Revenue from services | 200,000us-gaap_SalesRevenueServicesNet / dei_LegalEntityAxis = opk_NeovascMember |
100,000us-gaap_SalesRevenueServicesNet / dei_LegalEntityAxis = opk_NeovascMember |
|
Minimum | |||
Summary of Significant Accounting Policies [Line Items] | |||
Intangible assets, estimated useful lives | 3 years | ||
Maximum | |||
Summary of Significant Accounting Policies [Line Items] | |||
Intangible assets, estimated useful lives | 10 years | ||
Restatement Adjustment | |||
Summary of Significant Accounting Policies [Line Items] | |||
Net cash used in operating activities | (6,400,000)us-gaap_NetCashProvidedByUsedInOperatingActivities / us-gaap_StatementScenarioAxis = us-gaap_RestatementAdjustmentMember |
||
Net cash provided by financing activities | 6,400,000us-gaap_NetCashProvidedByUsedInFinancingActivities / us-gaap_StatementScenarioAxis = us-gaap_RestatementAdjustmentMember |
||
Pfizer [Member] | |||
Summary of Significant Accounting Policies [Line Items] | |||
Revenue from sale of intellectual property | $ 12,500,000opk_RevenueFromSaleOfIntellectualProperty / us-gaap_CounterpartyNameAxis = opk_PfizerMember |
X | ||||||||||
- Definition
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Goodwill and Intangible Assets No definition available.
|
X | ||||||||||
- Definition
Revenue From Sale Of Intellectual Property No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. No definition available.
|
X | ||||||||||
- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. No definition available.
|
X | ||||||||||
- Definition
Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|